Salivary Cortisol and Soluble Tumor Necrosis Factor-Α Receptor II Responses to Multiple Experimental Modalities of Acute Pain

Psychophysiology - United Kingdom
doi 10.1111/j.1469-8986.2011.01280.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Enhanced Cortisol Increase Upon Awakening Is Associated With Greater Pain Ratings but Not Salivary Cortisol or Soluble Tumor Necrosis Factor-Α Receptor II Responses to Acute Pain

Clinical Journal of Pain
NeurologyAnesthesiologyPain Medicine
2012English

Salivary Cortisol Responses to Acute Stress in Students With Myofascial Pain

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2018English

Responses of Salivary Cortisol and Α-Amylase to Official Competition

Journal of Human Sport and Exercise
Physical TherapySports TherapyRehabilitationSports Science
2011English

Selective Activation of Tumor Necrosis Factor Receptor 2 Induces Anti-Inflammatory Responses and Alleviates Experimental Arthritis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Implications of Dynamic Changes Among Tumor Necrosis Factor-Α (TNF-α), Membrane TNF Receptor, and Soluble TNF Receptor Levels in Regard to the Severity of Dengue Infection

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2007English

Soluble Tumor Necrosis Factor Receptor Type I Enhances Tumor Development and Persistence in Vivo

Cellular Immunology
Immunology
2000English

CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

A Dual Target-Directed Agent Against Interleukin-6 Receptor and Tumor Necrosis Factor Α Ameliorates Experimental Arthritis

Scientific Reports
Multidisciplinary
2016English

The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble Versus Membrane-Bound Ligand

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy